Since 1991, MedPass has helped to advance the development of breakthrough medical device technologies. We offer a broad range of strategic and operational services tailored to meet the needs of our clients. Throughout the years, MedPass has developed and maintained excellent relationships with sites and investigators in Europe covering all therapeutics areas.
MedPass has conducted hundreds of clinical trials from Early Feasibility or First-In-Man Studies to Post-Market Follow-up Clinical Studies. We have implemented clinical trials in all of the EU countries covering all therapeutics areas mentioned above. Of note, MedPass has been through several successful audits by FDA and other EU regulatory bodies.
At MedPass we believe the therapeutic expertise of the CRO is of the highest importance for ensuring the optimum conduct of the trial. For almost 30 years, MedPass has gained considerable experience with the full spectrum of therapeutics areas.
List of Therapeutic Areas
- ENDOVASCULAR / PERIPHERAL VASCULAR
- NEUROLOGY / NEUROVASCULAR
- URGI TRACT / LIVER
GET IN TOUCH WITH MEDPASS
MedPass employs approximately 100 FTE in the EU, half of which are based at our Headquarters in Paris, France, and half being home based and located throughout Europe. All clinical staff are fully trained to EN ISO 14155, ICH GCP, FDA CFR Part 810 and national regulations on medical devices (MPG, etc.). Our CRAs are Senior, located close to the sites, and speak the local language.